
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
STRATA Skin Sciences Inc (SSKN)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/31/2025: SSKN (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $8
1 Year Target Price $8
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.92% | Avg. Invested days 13 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 10.12M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 2 | Beta 0.51 | 52 Weeks Range 1.38 - 3.86 | Updated Date 11/1/2025 |
52 Weeks Range 1.38 - 3.86 | Updated Date 11/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.84 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -35.13% | Operating Margin (TTM) -29.02% |
Management Effectiveness
Return on Assets (TTM) -11.13% | Return on Equity (TTM) -235.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 21293225 | Price to Sales(TTM) 0.31 |
Enterprise Value 21293225 | Price to Sales(TTM) 0.31 | ||
Enterprise Value to Revenue 0.65 | Enterprise Value to EBITDA -7008.83 | Shares Outstanding 5684508 | Shares Floating 1691948 |
Shares Outstanding 5684508 | Shares Floating 1691948 | ||
Percent Insiders 10.13 | Percent Institutions 57.24 |
Upturn AI SWOT
STRATA Skin Sciences Inc

Company Overview
History and Background
STRATA Skin Sciences, Inc. (formerly PhotoMedex, Inc.) was founded in 1989. The company focuses on developing and commercializing innovative products for the treatment of dermatological conditions. Over the years, STRATA has evolved through acquisitions and internal development, solidifying its position in the medical dermatology market.
Core Business Areas
- Dermatology Devices: STRATA Skin Sciences develops, markets, and sells medical devices used in the treatment of various skin conditions, including psoriasis, vitiligo, and acne.
- Pharma: STRATA develops and markets pharma solutions for skin conditions
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives overseeing various departments such as marketing, sales, R&D, and operations. The organizational structure is typically hierarchical, with functional departments reporting to executive management.
Top Products and Market Share
Key Offerings
- XTRAC Laser: The XTRAC laser system is used for the treatment of psoriasis and vitiligo. Market share data for XTRAC is difficult to ascertain as it depends on the specific market segment (psoriasis/vitiligo devices). Key competitors include laser systems from companies like Candela and Cutera. Revenue figures for XTRAC are not publicly available.
- PHAROS Excimer Laser: PHAROS is another excimer laser used to treat skin conditions, similar to XTRAC. Market share and revenue data are not broken out separately for PHAROS. Competitors are the same as XTRAC.
- Rhofade (oxymetazoline HCl) cream, 1%: Rhofade is a topical medication indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. Competitors include Mirvaso (brimonidine) and generics. Revenue numbers are unavailable.
Market Dynamics
Industry Overview
The medical dermatology device and pharma market is driven by increasing prevalence of skin conditions, advancements in technology, and growing demand for non-invasive treatment options. The market is competitive, with several established players and emerging companies.
Positioning
STRATA Skin Sciences is positioned as a key player in the dermatology market with its innovative laser systems and treatments. Their competitive advantage lies in the XTRAC laser and its effectiveness for targeted treatment.
Total Addressable Market (TAM)
The total addressable market for dermatology devices and treatments is estimated to be in the billions of dollars. STRATA is positioned to capture a portion of this market through continued product innovation and market expansion. Specific TAM figures are not readily available for their niche.
Upturn SWOT Analysis
Strengths
- Established product portfolio
- Strong brand recognition in the dermatology market
- Proprietary laser technology
- Experienced management team
Weaknesses
- High operating expenses
- Dependence on key products
- Limited financial resources compared to larger competitors
- Small market cap and stock volatility
Opportunities
- Expansion into new geographic markets
- Development of new products and technologies
- Strategic partnerships and acquisitions
- Increasing demand for non-invasive treatments
Threats
- Intense competition
- Regulatory changes
- Technological obsolescence
- Economic downturns affecting healthcare spending
Competitors and Market Share
Key Competitors
- CYTK
- ALGN
- LMNR
Competitive Landscape
STRATA Skin Sciences faces strong competition from established players in the dermatology market. They compete on product innovation, pricing, and distribution. Larger competitors have more resources for marketing and R&D.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been variable depending on product adoption and sales. Growth rates have been moderate.
Future Projections: Future projections are based on analyst estimates. These projections are not available for direct JSON output.
Recent Initiatives: Recent initiatives may include new product launches, marketing campaigns, and strategic partnerships.
Summary
STRATA Skin Sciences is a player in the dermatology market with its laser systems and treatments. Its strengths lie in the established product portfolio. The company faces challenges related to its small size, financial resources, and market competition. Growth opportunities exist through geographic expansion and new product development.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Analyst Reports (General)
Disclaimers:
Data is based on publicly available information and may not be fully comprehensive. Market share data is estimated and may not be precise. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About STRATA Skin Sciences Inc
Exchange NASDAQ | Headquaters Horsham, PA, United States | ||
IPO Launch date 2005-10-28 | President, CEO & Vice-Chairman Dr. Dolev Rafaeli Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 106 | |
Full time employees 106 | |||
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

